NCT01346267 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 83
- group Id
- BG001
- value
- 82
- group Id
- BG002
- value
- 165
- units
- Participants
- groups
- description
- Patients wear Sea-Band acupressure wristbands on each wrist beginning approximately 30 minutes prior to the first cisplatin-containing chemotherapy course and continually for 24 hours after the last chemotherapy dose (acute phase), and for a maximum of 7 days or until the next chemotherapy course starts (delayed phase). Patients are allowed to take bands off intermittently (up to 4 times a day, for no more than 15 minutes each time) to relieve pressure or to bathe. Patients also receive standard of care anti-emetic prophylaxis comprising granisetron, ondansetron, or dexamethasone during chemotherapy according to institutional or physician preference. Real Acupressure Band: Acupressure wristband
- id
- BG000
- title
- Arm I- Real Acupressure Bands
- description
- Patients wear placebo wristbands on each wrist and receive standard of care anti-emetic prophylaxis during chemotherapy as patients in arm I. Placebo Acupressure Band: Sham wristband
- id
- BG001
- title
- Arm II- Placebo Acupressure Bands
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 4.3
- value
- 12.5
- group Id
- BG001
- spread
- 4.2
- value
- 12.9
- group Id
- BG002
- spread
- 4.2
- value
- 12.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 69
- title
- Female
- measurements
- group Id
- BG000
- value
- 46
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 96
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 33
- title
- Osteosarcoma
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 49
- title
- Hodgkin Lymphoma
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 15
- title
- Ewing Sarcoma
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 68
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Diagnosis
- unit Of Measure
- Participants
- population Description
- 93 participants were allocated to acupressure bands and 83 received the intervention. 94 participants were allocated to the placebo bands and 82 received the intervention.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 83
- group Id
- BG001
- value
- 82
- group Id
- BG002
- value
- 165
- units
- Participants
- groups
- description
- Patients wear Sea-Band acupressure wristbands on each wrist beginning approximately 30 minutes prior to the first cisplatin-containing chemotherapy course and continually for 24 hours after the last chemotherapy dose (acute phase), and for a maximum of 7 days or until the next chemotherapy course starts (delayed phase). Patients are allowed to take bands off intermittently (up to 4 times a day, for no more than 15 minutes each time) to relieve pressure or to bathe. Patients also receive standard of care anti-emetic prophylaxis comprising granisetron, ondansetron, or dexamethasone during chemotherapy according to institutional or physician preference. Real Acupressure Band: Acupressure wristband
- id
- BG000
- title
- Arm I- Real Acupressure Bands
- description
- Patients wear placebo wristbands on each wrist and receive standard of care anti-emetic prophylaxis during chemotherapy as patients in arm I. Placebo Acupressure Band: Sham wristband
- id
- BG001
- title
- Arm II- Placebo Acupressure Bands
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 4.3
- value
- 12.5
- group Id
- BG001
- spread
- 4.2
- value
- 12.9
- group Id
- BG002
- spread
- 4.2
- value
- 12.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 69
- title
- Female
- measurements
- group Id
- BG000
- value
- 46
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 96
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 33
- title
- Osteosarcoma
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 49
- title
- Hodgkin Lymphoma
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 15
- title
- Ewing Sarcoma
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 68
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Diagnosis
- unit Of Measure
- Participants
- population Description
- 93 participants were allocated to acupressure bands and 83 received the intervention. 94 participants were allocated to the placebo bands and 82 received the intervention.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle